A Rare Association of Dyke–Davidoff–Masson Syndrome with a Specific Learning Disability

Article information

Ann Child Neurol. 2026;34(4):330-333
Publication date (electronic) : 2026 September 28
doi : https://doi.org/10.26815/acn.2026.01711
1Department of Pediatrics, Base Hospital, Delhi, India
2Department of Medicine, Base Hospital, Delhi, India
Corresponding author: Rahul Sinha, DM Department of Pediatrics, Base Hospital, Delhi 110010, India Tel: +91-8800630109 E-mail: drrahul_2000@yahoo.com
Received 2026 June 20; Revised 2026 August 28; Accepted 2026 September 4.

In children, the clinical and radiological triad of hemiparesis, hemiatrophy, and focal epilepsy occurs in several neurological disorders, most commonly stroke sequelae, Rasmussen encephalitis (RE), hemiconvulsion–hemiplegia–epilepsy (HHE) syndrome, and mitochondrial disorders. Dyke–Davidoff–Masson syndrome (DDMS) is a rare but important differential diagnosis, characterized by hemiparesis, focal seizures, and variable intellectual impairment or behavioral concerns [1]. Characteristic imaging findings include cerebral hemiatrophy, ipsilateral lateral ventricular enlargement, compensatory skull hypertrophy, and sinus hyperpneumatization [2]. Although the etiology remains uncertain, most cases are associated with early developmental insults, including infarction, ischemia, hemorrhage, infection, or trauma. The precipitating injury occurs during fetal life or early childhood, but clinical manifestations may emerge later, and the diagnosis is generally confirmed by neuroimaging [3]. Specific learning disabilities are reported less frequently in DDMS and may be overlooked because motor deficits and epilepsy are more clinically prominent. We report a rare case of DDMS in an 8-year-old girl with refractory focal seizures and specific learning disability.

An 8-year-old girl who had developed typically until age 3 years presented with refractory focal epilepsy. Her early development was age appropriate, and she had appeared asymptomatic until age three, when frequent right-sided focal faciobrachiocrural seizures lasting 1–3 minutes began. Most initial seizures were triggered by fever. Seizures continued at a frequency of 1–2 per month despite treatment with two antiseizure medications. At the time seizures began, her parents also noticed gradually developing, nonprogressive weakness of the right side of her body. Her school performance was average, with difficulty performing calculations, frequent spelling errors, and poor handwriting. There was no history of acute febrile encephalopathy, stroke, prolonged loss of consciousness, or status epilepticus. The perinatal period had been uneventful, and the family history was noncontributory. Physical examination showed age-appropriate anthropometric measurements and mild right facial hemiatrophy. No dysmorphic features or neurocutaneous markers were present. Neurobehavioral assessment using Malin’s Intelligence Scale for Indian Children showed an intelligence quotient of 86 (average intelligence) [4]. Screening with the National Institute of Mental Health and Neurosciences battery for specific learning disabilities identified dyscalculia and dysgraphia [5]. Motor examination revealed a hemiparetic gait, spasticity, and asymmetric pyramidal signs in the right upper and lower limbs. Muscle strength was 4/5 in the right upper limb and 3+/5 in the right lower limb. Sensory and cerebellar examinations were normal, as were examinations of the other systems. The complete blood count and routine biochemical results were within normal limits. Arterial lactate was 0.8 mmol/L (reference range, 0.2 to 1.8). Electroencephalography (EEG) during drug-induced sleep, using the international 10–20 system, showed an asymmetrically slow background over the left hemisphere, with frequent interictal epileptiform discharges in the left centroparietal region. Brain magnetic resonance imaging (MRI) at age 4 years showed left cerebral volume loss, widening of the ipsilateral sulci and Sylvian fissure, prominence of the left lateral ventricle and cortical sulci, and ipsilateral calvarial thickening (Fig. 1A). Repeat brain MRI at age 7 years showed no progression of left cerebral cortical atrophy (Fig. 1B). DDMS was diagnosed on the basis of these imaging findings, and oxcarbazepine, gradually increased to 25 mg/kg/day, and clobazam were initiated. Valproic acid was tapered and discontinued. Home-based constraint-induced movement therapy was started for hemiparesis, and a remedial program for specific learning disability was initiated under the supervision of our clinical psychologist. During 1 year of follow-up, the child experienced only two brief seizures, and her school performance improved steadily.

Fig. 1.

(A) T2-weighted axial magnetic resonance image at age 4 years showing left cerebral hemiatrophy, prominence of the left lateral ventricle and cortical sulci (red arrows), and ipsilateral calvarial thickening (white arrow). (B) T2-weighted axial magnetic resonance image at age 7 years showing similar findings without progression (red and white arrows).

DDMS is a rare clinical and radiological disorder that typically presents in children and adolescents with refractory focal seizures or neuropsychiatric manifestations. The classic triad comprises hemiparesis, hemiatrophy, and focal seizures, although the recognized clinical spectrum continues to expand [6]. Typical imaging findings include unilateral cerebral atrophy or hypoplasia with ipsilateral ventricular dilation, compensatory calvarial thickening, and sinus hyperpneumatization [7]. Specific learning disabilities are infrequently reported in DDMS and may be underrecognized because epilepsy, hemiparesis, and other prominent motor deficits often dominate the presentation [8]. Psychiatric manifestations, including aggression, irritability, mood disturbances, and psychotic symptoms, have also been reported [9,10]. Frontal network abnormalities may contribute to behavioral dysregulation, but a single case cannot establish a causal relationship between hemispheric structural changes and learning disability. Other causes of cerebral hemiatrophy, hemiparesis, and focal epilepsy in children—including RE, Sturge–Weber syndrome (SWS), stroke sequelae, HHE syndrome, and mitochondrial disorders—can closely resemble DDMS clinically and radiologically. Early differentiation is important because management differs, ranging from aggressive immunomodulation and surgery in RE and HHE syndrome to stroke prophylaxis in SWS and stroke. Table 1 summarizes the key clinical, radiological, and EEG features that distinguish these conditions. Stable findings on serial imaging and calvarial hemihypertrophy are relatively specific for DDMS. Compensatory calvarial thickening may result from unilateral loss of brain volume. In early childhood, before calvarial maturation is complete, arrested growth of one cerebral hemisphere can cause inward expansion of the diploic space and thickening of the inner table, together with enlargement of the frontal sinus and elevation of the greater wing of the sphenoid and petrous ridge on the affected side [10].

Differential diagnosis of Dyke–Davidoff–Masson syndrome

This case emphasizes DDMS as an important differential diagnosis in children with the clinical and radiological triad of hemiparesis, hemiatrophy, and focal seizures. Neurologists and epileptologists should recognize this distinct, multifactorial disorder and its association with learning disorders. Early differentiation from RE, HHE syndrome, and stroke is essential to guide management. Most patients respond to conservative management, including optimization of antiseizure medication, physiotherapy, and behavioral interventions for neurobehavioral concerns.

The authors confirm that all appropriate patient consent forms were obtained.

Notes

Conflicts of interest

No potential conflict of interest relevant to this article was reported.

Author contribution

Conceptualization: RS and RK. Data curation: RS and NT. Formal analysis: RS, VKJ, NK, VS, and HP. Visualization: NK. Writing - original draft: RS and VS. Writing - review & editing: VKJ, NT, RK, and HP.

Acknowledgments

The authors thank the staff of the Department of Pediatrics, Base Hospital, Delhi Cantt, for their assistance with the patient’s care and manuscript preparation.

References

1. Aguiar PH, Liu CW, Leitao H, Issa F, Lepski G, Figueiredo EG, et al. MR and CT imaging in the Dyke-Davidoff-Masson syndrome. Report of three cases and contribution to pathogenesis and differential diagnosis. Arq Neuropsiquiatr 1998;56:803–7. 10.1590/s0004-282x1998000500016. 10029885.
2. Singh P, Saggar K, Ahluwalia A. Dyke-Davidoff-Masson syndrome: classical imaging findings. J Pediatr Neurosci 2010;5:124–5. 10.4103/1817-1745.76108. 21559157.
3. Koshy B, Surendrababu NR. Image in medicine. Dyke-Davidoff-Masson syndrome. Ann Acad Med Singap 2010;39:501–2. 10.47102/annals-acadmedsg.v39n6p501. 20625632.
4. Malin AJ. Manual for Malin's intelligence scale for Indian children (MISIC). Lucknow: Indian Psychological Corporation; 1969.
5. Kapur M, John A, Rozario J, Oommen A. NIMHANS index of specific learning disabilities. In : Hirisave U, Oommen A, Kapur M, eds. Psychological assessment of children in the clinical setting Bangalore: Samudra Offset Printers; 2006. p. 72–121.
6. Dutta A, Bose S, Sen K, Pandit N, Sharma S. Refractory seizure in childhood: Dyke-Davidoff-Masson syndrome revisited. Oman Med J 2016;31:304–8. 10.5001/omj.2016.58. 27403244.
7. Sharma S, Goyal D, Negi A, Sood RG, Jhobta A, Surya M. Dyke-Davidoff Masson syndrome. Indian J Radiol Imaging 2006;16:165–6. 10.4103/0971-3026.29077.
8. Younas A, Saim M, Maqsood H, Younus S, Raza MH. Dyke-Davidoff-Masson syndrome: a case report and review of literature. Cureus 2020;12e11919. 10.7759/cureus.11919. 33425504.
9. White JH, Rust JB. Davidoff-Dyke-Masson syndrome presenting as childhood schizophrenia. J Autism Dev Disord 1979;9:37–40. 10.1007/bf01531290. 571429.
10. Nugrahanto AP, Indraswari BW, Nurputra DK, Triono A, Herini ES. Etiologic insights from magnetic resonance angiography in Dyke–Davidoff–Masson syndrome presenting with aggressive behavior. Ann Child Neurol 2026;34:251–4. 10.26815/acn.2026.01368.

Article information Continued

Fig. 1.

(A) T2-weighted axial magnetic resonance image at age 4 years showing left cerebral hemiatrophy, prominence of the left lateral ventricle and cortical sulci (red arrows), and ipsilateral calvarial thickening (white arrow). (B) T2-weighted axial magnetic resonance image at age 7 years showing similar findings without progression (red and white arrows).

Table 1.

Differential diagnosis of Dyke–Davidoff–Masson syndrome

Characteristic DDMS RE HHE SWS Stroke Mitochondrial disorders, especially MELAS
Seizures Present Definitely present Definitely present May or may not be present May or may not be present Present
Hemiparesis Static Worsening Static Improving Improving Recurrent
Intellectual disability May or may not be present Present May or may not be present Present May or may not be present May or may not be present
Neuropsychiatric features Present Present May or may not be present Not present May or may not be present May or may not be present
Skin lesions Absent Absent Absent Port-wine stain Absent Absent
Calcification Absent Absent Absent Tram-track calcification May or may not be present Absent
Unilateral cerebral atrophy Present (nonprogressive) Present (progressive) Present (nonprogressive) Present (progressive) Present (nonprogressive) Typically bilateral, although sometimes asymmetric, often involving the basal ganglia or multiple focal regions
Basal ganglia involvement Present Definitely present Absent Absent Present Bilateral involvement
Calvaria Hemihypertrophy Normal Normal May be thickened Normal Normal
Sinus Hyperpneumatization Normal Normal Normal Normal Normal
Angiographic abnormalities May or may not be present Absent Absent Present Present Absent
Electroencephalography Hemispheric slowing with interictal epileptiform discharges  Hemispheric slowing with interictal epileptiform discharges and ictal pattern Background slowing in the affected hemisphere Focal slowing to sharp-wave discharges Rhythmic and periodic patterns; interictal epileptiform discharges Focal or generalized epileptiform discharges
Focal/multifocal epileptiform abnormalities in the affected hemisphere (chronic phase)
Multisystem involvement Absent Absent Absent May be present Absent Present
Metabolic markers Normal serum and CSF biomarkers Normal serum and CSF biomarkers Normal serum and CSF biomarkers Normal serum and CSF biomarkers Normal serum and CSF biomarkers Elevated blood/CSF lactate and pyruvate; elevated alanine

DDMS, Dyke–Davidoff–Masson syndrome; RE, Rasmussen encephalitis; HHE, hemiconvulsion–hemiplegia–epilepsy; SWS, Sturge–Weber syndrome; MELAS, mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes; CSF, cerebrospinal fluid.